AIMS: High-flow arteriovenous fistula (AVF) for haemodialysis leads to profound haemodynamic changes and sometimes to heart failure (HF). Cardiac output (CO) is divided between the AVF and body tissues. The term effective CO (COef) represents the difference between CO and AVF flow volume (Qa) and better characterizes the altered haemodynamics that may result in organ hypoxia. We investigated the effects of Qa reduction on systemic haemodynamics and on brain oxygenation. METHODS AND RESULTS: This is a single-centre interventional study. Twenty-six patients on chronic haemodialysis with high Qa (>1500 mL/min) were indicated for surgical Qa reduction for HF symptoms and/or signs of structural heart disease on echocardiography. The included patients underwent three sets of examinations: at 4 months and then 2 days prior and 6 weeks post-surgical procedure. Clinical status, echocardiographical haemodynamic assessment, Qa, and brain oximetry were recorded. All parameters remained stable from selection to inclusion. After the procedure, Qa decreased from 3.0 ± 1.4 to 1.3 ± 0.5 L/min, P < 0.00001, CO from 7.8 ± 1.9 to 6.6 ± 1.5 L/min, P = 0.0002, but COef increased from 4.6 ± 1.4 to 5.3 ± 1.4 L/min, P = 0.036. Brain tissue oxygen saturation increased from 56 ± 11% to 60 ± 9%, P = 0.001. CONCLUSIONS: Qa reduction led to increased COef. This was explained by a decreased proportion of CO running through the AVF in patients with Qa > 2.0 L/min. These observations were mirrored by higher brain oxygenation and might explain HF symptoms and improved haemodynamics even in asymptomatic high Qa patients.

2nd Department of Surgery General University Hospital 1st Faculty of Medicine Charles University Prague Czech Republic

3rd Department of Internal Medicine General University Hospital 1st Faculty of Medicine Charles University U Nemocnice 1 Prague 128 08 Czech Republic

Department of Medicine University of Virginia Health System Charlottesville VA USA

Department of Nephrology General University Hospital 1st Faculty of Medicine Charles University Prague Czech Republic

See more in PubMed

Alhaj E, Alhaj N, Tahman I, Niazi TO, Berkowitz R, Klapholz M. Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail 2013; 19: E40–E45. PubMed

Yeh LM, Chiu SY, Lai PC. The impact of vascular access types on hemodialysis patient long‐term survival. Sci Rep 2019; 9: 10708. PubMed PMC

Savage MT, Ferro CJ, Sassano A, Tomson CRV. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. Am J Kidney Dis 2002; 40: 753–759. PubMed

Malik J. Heart disease in chronic kidney disease—review of the mechanisms and the role of dialysis access. J Vasc Access 2018; 19: 3–11. PubMed

Basile C, Lomonte C. The complex relationship among arteriovenous access, heart, and circulation. Semin Dial 2018; 31: 15–20. PubMed

Amerling R, Ronco C, Kuhlmann M, Winchester JF. Arteriovenous fistula toxicity. Blood Purif 2011; 31: 113–120. PubMed

Mehta PA, Dubrey SW. High output heart failure. QJM 2009; 102: 235–241. PubMed

Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, Macaulay E, Russell CH, Olakkengil S, Carroll RP, Faull RJ, Teo KSL, McDonald SP, Worthley MI, Coates PT. Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation 2019; 139: 2809–2818. PubMed

Michna M, Kovarova L, Valerianova A, Malikova H, Weichet J, Malik J. Review of the structural and functional brain changes associated with chronic kidney disease. Physiol Res 2020; 69: 1013–1028. PubMed PMC

Malik J, Kudlicka J, Lachmanva J, Valerianova A, Rocinova K, Bartkova M, Tesar V. Tissue ischemia worsens during hemodialysis in end‐stage renal disease patients. J Vasc Access 2017; 18: 47–51. PubMed

Kovarova L, Valerianova A, Jmentova T, Lachmanova J, Hladinova Z, Malik J. Low cerebral oxygenation is associated with cognitive impairment in chronic hemodialysis patients. Nephron 2018; 139: 113–119. PubMed

Miyazawa H, Ookawara IK, Ueda Y, Yanai K, Ishii H, Mutsuyoshi Y, Kitano T, Shindo M, Aomatsu A, Hirai K, Hoshino T, Morishita Y. Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy. PLoS One 2018; 13: e0199366. PubMed PMC

Kovarova L, Valerianova A, Michna M, Malik J. Short‐term manual compression of hemodialysis fistula leads to a rise in cerebral oxygenation. J Vasc Access Published Online First: 3 June 2020. PubMed

Ponikowski P, Voors SA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez‐Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016; 18: 891–975. PubMed

Reddy YN, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High‐output heart failure: a 15‐year experience. J Am Coll Cardiol 2016; 68: 473–482. PubMed

Sanchez MM, Binkowitz BS. Guidelines for measurement validation in clinical trial design. J Biopharm Stat 1999; 9: 417–438. PubMed

Antlanger M, Aschauer S, Kopecky C, Hecking M, Kovarik JJ, Werzowa J, Mascherbauer J, Genser B, Saemann MD, Bonderman D. Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Press Res 2017; 42: 165–176. PubMed

Chawla LS, Herzog CA, Costanzo MR, Tumlin J, Kellum JA, McCullough PA, Ronco C. Proposal for a functional classification system of heart failure in patients with end‐stage renal disease: proceedings of the Acute Dialysis Quality Initiative (ADQI) XI Workgroup. J Am Coll Cardiol 2014; 63: 1246–1252. PubMed

Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Lumachi C, Perna AM, Boddi M, Gensini GF. Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension 2003; 43: 101–108. PubMed

Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA. Long‐term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease. Eur Heart J 2017; 38: 1913–1923. PubMed

Bolignano D, Rastelli S, Agarwall R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez‐Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Mallamaci F, London G, Zoccali C. Pulmonary hypertension in CKD. Am J Kidney Dis 2013; 61: 612–622. PubMed

McIntyre CW, Crowley L. Dying to feel better: the central role of dialysis‐induced tissue hypoxia. Clin J Am Soc Nephrol 2016; 11: 549–551. PubMed PMC

Valerianova A, Lachamova J, Kovarova L, Kmentova T, Bartkova M, Malik J. Factors responsible for cerebral hypoxia in hemodialysis population. Physiol Res 2019; 68: 651–658. PubMed

Ito K, Ookawara S, Ueda Y, Goto S, Miyazawa H, Yamada H, Kitano T, Shindo M, Kaku Y, Hirai K, Yoshida M, Hoshino T, Nabata A, Mori H, Yashida I, Kakei M, Tabein K. Factors affecting cerebral oxygenation in hemodialysis patients: cerebral oxygenation associates with pH, hemodialysis duration, serum albumin concentration, and diabetes mellitus. PLoS One 2015; 10: e0117474. PubMed PMC

Harrison LE, Selby NM, McIntyre CW. Central venous oxygen saturation: a potential new marker for circulatory stress in haemodialysis patients? Nephron Clin Pract 2014; 128: 57–60. PubMed

Matsukawa S, Kai S, Mizota T. Near‐infrared spectroscopy underestimates cerebral oxygenation in hemodialysis patients. J Anesth 2019; 33: 478–481. PubMed

Vaes RHD, van Loon M, Vaes SMM, Cuypers P, Tordoir JH, Scheltinga MR. One‐year efficacy of the RUDI technique for flow reduction in high‐flow autologous brachial artery‐based hemodialysis vascular access. J Vasc Access 2015; 16: S96–S101. PubMed

Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications

Management of Arteriovenous Fistula After Successful Kidney Transplantation in Long-Term Follow-Up

Non-invasively assessed haemodynamics in patients with high flow arteriovenous fistula and high output cardiac failure

A large arteriovenous fistula steals a considerable part of systemic blood flow during veno-arterial extracorporeal circulation support in a porcine model

Comparing the hemodynamic effect of a large arteriovenous fistula during high and low cardiac output states

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

New Porcine Model of Arteriovenous Fistula Documents Increased Coronary Blood Flow at the Cost of Brain Perfusion